|
|
EQSNews: aap Implantate AG
/ Key words: Personnel
aap CFO Marek Hahn ends his Management Board activities at the end of the year; contracts of CEO and COO extended until the end of 2025
25.05.2023 / 17:52 CET/CEST
The issuer is solely responsible for the content of this announcement.
CFO Marek H... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Quarter Results
Q1/2023: Solid start with slight sales growth 3 % and unchanged EBITDA; US and LATAM business grow well into double digits
15.05.2023 / 10:32 CET/CEST
The issuer is solely responsible for the content of this announcement.
Sales: EUR... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Annual Report/Annual Results
Consolidation in FY/2022: Small decline in sales with stable cost base and strong improvement in operating cash flow 23 % in challenging environment
28.04.2023 / 11:50 CET/CEST
The issuer is solely responsible for the content of this announcement.
&... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Agreement/Contract
aap Implants Inc. awarded agreement with Premier, Inc. for Small Joint Implants – Upper Extremities, Small Joint Implants – Lower Extremities, Podiatry Products and Accessories
03.04.2023 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Regulatory Approval/Market Launch
aap receives USAmerican clearance FDA for polyaxial LOQTEQ® VA Elbow system; launch planned for Q4 2023
21.03.2023 / 09:08 CET/CEST
The issuer is solely responsible for the content of this announcement.
aap Implantate AG ... Lire le communiqué |
|
| |
|
| |
|
|
EQSAdhoc: aap Implantate AG / Key words: Capital Increase/Financing
Result of the capital increase with subscription rights: capital measure fully subscribed; issue of 2.4 million new shares leads to gross issue proceeds of around EUR 3.3 million
15March2023 / 20:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Capital Increase/Development of Sales
Good start in 2023 after challenging fiscal year 2022
21.02.2023 / 13:16 CET/CEST
The issuer is solely responsible for the content of this announcement.
Sales: Good start in January 2023 in the U.S. with doubledigit s... Lire le communiqué |
|
| |
|
| |
